相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The role of tolerogenic dendritic cells in systematic lupus erythematosus progression and remission
Bita Mohammadi et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2023)
Preventing Hepatitis B Virus Infection Among US Military Personnel: Potential Impact of a 2-Dose Versus 3-Dose Vaccine on Medical Readiness
Kimberly A. Oelschlager et al.
MILITARY MEDICINE (2023)
Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies
Changyu Yao et al.
CANCER BIOLOGY & MEDICINE (2023)
Use of a Liver-Targeting Immune-Tolerogenic mRNA Lipid Nanoparticle Platform to Treat Peanut-Induced Anaphylaxis by Single- and Multiple-Epitope Nucleotide Sequence Delivery
Xiao Xu et al.
ACS NANO (2023)
The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma
Romain Donne et al.
HEPATOLOGY (2023)
Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors
Daniel Q. Huang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2023)
Current Strategies for Modulating Tumor-Associated Macrophages with Biomaterials in Hepatocellular Carcinoma
Qiaoyun Liu et al.
MOLECULES (2023)
Role of CD147 in the development and diagnosis of hepatocellular carcinoma
Defa Huang et al.
FRONTIERS IN IMMUNOLOGY (2023)
Mechanisms of organ fibrosis: Emerging concepts and implications for novel treatment strategies
Isabella Lurje et al.
MOLECULAR ASPECTS OF MEDICINE (2023)
Retinol-binding protein-hijacking nanopolyplex delivering siRNA to cytoplasm of hepatic stellate cell for liver fibrosis alleviation
Jinsheng Huang et al.
BIOMATERIALS (2023)
Understanding Nanomaterial-Liver Interactions to Facilitate the Development of Safer Nanoapplications
Jiulong Li et al.
ADVANCED MATERIALS (2022)
Getting to HBV cure: The promising paths forward
Scott Fung et al.
HEPATOLOGY (2022)
Baveno VII - Renewing consensus in portal hypertension
Roberto de Franchis et al.
JOURNAL OF HEPATOLOGY (2022)
Combination strategies with PD-1/PD-L1 blockade: current advances and future directions
Ming Yi et al.
MOLECULAR CANCER (2022)
Hyaluronated and PEGylated Liposomes as a Potential Drug-Delivery Strategy to Specifically Target Liver Cancer and Inflammatory Cells
Stefania Cannito et al.
MOLECULES (2022)
The mode of dexamethasone decoration influences avidin-nucleic-acid- nano-assembly organ biodistribution and in vivo drug persistence
Alberto Ongaro et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2022)
Nano delivery of simvastatin targets liver sinusoidal endothelial cells to remodel tumor microenvironment for hepatocellular carcinoma
Zhuo Yu et al.
JOURNAL OF NANOBIOTECHNOLOGY (2022)
Hepatitis C virus: A critical approach to who really needs treatment
Elias Kouroumalis et al.
WORLD JOURNAL OF HEPATOLOGY (2022)
Anionic Lipid Nanoparticles Preferentially Deliver mRNA to the Hepatic Reticuloendothelial System
Roy Pattipeiluhu et al.
ADVANCED MATERIALS (2022)
Strategies for active tumor targeting-an update
Darshan Vyas et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2022)
Hepatic stellate cells in the injured liver: Perspectives beyond hepatic fibrosis
Devaraj Ezhilarasan
JOURNAL OF CELLULAR PHYSIOLOGY (2022)
Drug delivery of sofosbuvir drug capsulated with the β-cyclodextrin basket loaded on chitosan nanoparticle surface for anti-hepatitis C virus (HCV)
Nagi M. El-Shafai et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2022)
Injectable in situ intelligent thermo-responsive hydrogel with glycyrrhetinic acid-conjugated nano graphene oxide for chemo-photothermal therapy of malignant hepatocellular tumor
Huahua Wang et al.
JOURNAL OF BIOMATERIALS APPLICATIONS (2022)
Modulating tumor-associated macrophages to enhance the efficacy of immune checkpoint inhibitors: A TAM-pting approach
Ali N. Chamseddine et al.
PHARMACOLOGY & THERAPEUTICS (2022)
Inhibition of Metastatic Hepatocarcinoma by Combined Chemotherapy with Silencing VEGF/VEGFR2 Genes through a GalNAc-Modified Integrated Therapeutic System
Xunan Li et al.
MOLECULES (2022)
Targeted delivery to macrophages and dendritic cells by chemically modified mannose ligand-conjugated siRNA
Keiji Uehara et al.
NUCLEIC ACIDS RESEARCH (2022)
Hepatitis B Virus-Associated Hepatocellular Carcinoma
Giacomo Emanuele Maria Rizzo et al.
VIRUSES-BASEL (2022)
Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss
Sjaak Pouwels et al.
BMC ENDOCRINE DISORDERS (2022)
Celastrol: An Update on Its Hepatoprotective Properties and the Linked Molecular Mechanisms
Mengzhen Li et al.
FRONTIERS IN PHARMACOLOGY (2022)
Immunomodulatory Properties of Immune Checkpoint Inhibitors-More than Boosting T-Cell Responses?
Michael Kuske et al.
CANCERS (2022)
Gemcitabine and cisplatin plus durvalumab with or without tremelimumab in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, single-centre, phase 2 study
Do-Youn Oh et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2022)
A New Nano Adjuvant of PF3 Used for an Enhanced Hepatitis B Vaccine
Pu Shan et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2022)
Nanoparticle-Based Drug Delivery Systems for Induction of Tolerance and Treatment of Autoimmune Diseases
He Li et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2022)
Co-delivery of Interleukin-12 and doxorubicin loaded Nano-delivery system for enhanced immunotherapy with polarization toward M1-type Macrophages
Tushuai Li et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2022)
GA&HA-Modified Liposomes for Co-Delivery of Aprepitant and Curcumin to Inhibit Drug-Resistance and Metastasis of Hepatocellular Carcinoma
Yanying Li et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2022)
Celastrol-loaded lactosylated albumin nanoparticles attenuate hepatic steatosis in non-alcoholic fatty liver disease
Ni Fan et al.
JOURNAL OF CONTROLLED RELEASE (2022)
Autoimmune hepatitis: Challenges and novelties
Ignasi Olivas et al.
MEDICINA CLINICA (2022)
Bee venom-loaded EGFR-targeting peptide-coupled chitosan nanoparticles for effective therapy of hepatocellular carcinoma by inhibiting EGFR-mediated MEK/ERK pathway
Shaymaa Abdulmalek et al.
PLOS ONE (2022)
Genetic basis of defects in immune tolerance underlying the development of autoimmunity
Anne M. M. Hocking et al.
FRONTIERS IN IMMUNOLOGY (2022)
Nanostructured Lipid Carriers Loaded with Dexamethasone Prevent Inflammatory Responses in Primary Non-Parenchymal Liver Cells
Carolina Medina-Montano et al.
PHARMACEUTICS (2022)
Functional cRGD-Conjugated Polymer Prodrug for Targeted Drug Delivery to Liver Cancer Cells
Ru Zhou et al.
ACS OMEGA (2022)
Sequential Nano-Penetrators of Capillarized Liver Sinusoids and Extracellular Matrix Barriers for Liver Fibrosis Therapy
Ling-Feng Zhang et al.
ACS NANO (2022)
N-acetyl-galactosamine modified metal-organic frameworks to inhibit the growth and pulmonary metastasis of liver cancer stem cells through targeted chemotherapy and starvation therapy
Jing Hu et al.
ACTA BIOMATERIALIA (2022)
Recent Advances of α-Glucosidase Inhibitors: A Comprehensive Review
Neetu Agrawal et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2022)
ACT001 suppressing M1 polarization against inflammation via NF-?B and STAT1 signaling pathways alleviates acute lung injury in mice
Hui Guo et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2022)
Hepatocyte-targeted delivery of imiquimod reduces hepatitis B virus surface antigen
Nojoud Al Fayez et al.
JOURNAL OF CONTROLLED RELEASE (2022)
Engineered multifunctional nanocarriers for controlled drug delivery in tumor immunotherapy
Theodora Katopodi et al.
FRONTIERS IN ONCOLOGY (2022)
Treatment related toxicities with combination BRAF and MEK inhibitor therapy in resected stage III melanoma
Morgan Homan et al.
FRONTIERS IN ONCOLOGY (2022)
Inhibitory of active dual cancer targeting 5-Fluorouracil nanoparticles on liver cancer in vitro and in vivo
Mingrong Cheng et al.
FRONTIERS IN ONCOLOGY (2022)
Reactive Oxygen Species-Responsive Polypeptide Drug Delivery System Targeted Activated Hepatic Stellate Cells to Ameliorate Liver Fibrosis
Yumei Hao et al.
ACS NANO (2022)
DIVERSITY AND BIOLOGY OF CANCER-ASSOCIATED FIBROBLASTS
Giulia Biffi et al.
PHYSIOLOGICAL REVIEWS (2021)
Targeting hepatocyte growth factor/c-mesenchymal-epithelial transition factor axis in hepatocellular carcinoma: Rationale and therapeutic strategies
Jianqing Yu et al.
MEDICINAL RESEARCH REVIEWS (2021)
Antigen- and Epitope-Delivering Nanoparticles Targeting Liver Induce Comparable Immunotolerance in Allergic Airway Disease and Anaphylaxis as Nanoparticle-Delivering Pharmaceuticals
Qi Liu et al.
ACS NANO (2021)
SP94 peptide mediating highly specific and efficacious delivery of polymersomal doxorubicin hydrochloride to hepatocellular carcinoma in vivo
Jian Zhang et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2021)
The transformation of cancer-associated fibroblasts: Current perspectives on the role of TGF-β in CAF mediated tumor progression and therapeutic resistance
Bikash Chandra Jena et al.
CANCER LETTERS (2021)
Nanoparticle-mediated targeting of autoantigen peptide to cross-presenting liver sinusoidal endothelial cells protects from CD8 T-cell-driven autoimmune cholangitis
Antonella Carambia et al.
IMMUNOLOGY (2021)
Modified Lipid Nanocapsules for Targeted Tanshinone IIA Delivery in Liver Fibrosis
Asmaa A Ashour et al.
International Journal of Nanomedicine (2021)
Antigen-Presenting Cells in Food Tolerance and Allergy
Elise G. Liu et al.
FRONTIERS IN IMMUNOLOGY (2021)
Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1hiCD39+ CD4 T cells
Camille-Charlotte Balanca et al.
JCI INSIGHT (2021)
Hepatitis B Vaccines
Jade Pattyn et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Macrophage Activation Markers, Soluble CD163 and Mannose Receptor, in Liver Fibrosis
Rasmus Hvidbjerg Gantzel et al.
FRONTIERS IN MEDICINE (2021)
Recent updates on the management of autoimmune hepatitis
Atsumasa Komori
CLINICAL AND MOLECULAR HEPATOLOGY (2021)
Engineered therapeutic nanovaccine against chronic hepatitis B virus infection
Dongdong Qiao et al.
BIOMATERIALS (2021)
Controlled Drug Delivery Systems: Current Status and Future Directions
Shivakalyani Adepu et al.
MOLECULES (2021)
Immunosuppressive Nanoparticles for Management of Immune-Related Adverse Events in Liver
Shufang Shen et al.
ACS NANO (2021)
Chemo-photodynamic therapy with light-triggered disassembly of theranostic nanoplatform in combination with checkpoint blockade for immunotherapy of hepatocellular carcinoma
Jianjun Xu et al.
JOURNAL OF NANOBIOTECHNOLOGY (2021)
The Scavenger Function of Liver Sinusoidal Endothelial Cells in Health and Disease
Sabin Bhandari et al.
FRONTIERS IN PHYSIOLOGY (2021)
The transcatheter arterial chemoembolization combined with targeted nanoparticle delivering sorafenib system for the treatment of microvascular invasion of hepatocellular carcinoma
Dongna Su
BIOENGINEERED (2021)
Preferential Expression of Programmed Death Ligand 1 Protein in Tumor-Associated Macrophages and Its Potential Role in Immunotherapy for Hepatocellular Carcinoma
Dong-Jun Park et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Beyond the Usual Suspects: Hepatitis E Virus and Its Implications in Hepatocellular Carcinoma
Mara Kloehn et al.
CANCERS (2021)
Stabilin receptors clear LPS and control systemic inflammation
Fatima Cabral et al.
ISCIENCE (2021)
Liver sinusoidal endothelial cells are implicated in multiple fibrotic mechanisms
Heming Ma et al.
MOLECULAR BIOLOGY REPORTS (2021)
High-density lipoprotein modulates tumor-associated macrophage for chemoimmunotherapy of hepatocellular carcinoma
Junyang Wang et al.
NANO TODAY (2021)
From hepatitis A to E: A critical review of viral hepatitis
Daniel Castaneda et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2021)
Liver metastases
Diamantis I. Tsilimigras et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Orally administered saccharide-sequestering nanocomplex to manage carbohydrate metabolism disorders
Xin Zhao et al.
SCIENCE ADVANCES (2021)
CD4+ T Cells in Chronic Hepatitis B and T Cell-Directed Immunotherapy
Sonja I. Buschow et al.
CELLS (2021)
Macrophage Polarization States in the Tumor Microenvironment
Ava J. Boutilier et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Roles of CCL2-CCR2 Axis in the Tumor Microenvironment
Suguru Kadomoto et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Manipulation of TAMs functions to facilitate the immune therapy effects of immune checkpoint antibodies
Yang Liu et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Metabolic disorders and the risk of cholangiocarcinoma
Michele Ghidini et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2021)
Hepatitis Delta Virus (HDV) and Delta-Like Agents: Insights Into Their Origin
Hans J. Netter et al.
FRONTIERS IN MICROBIOLOGY (2021)
The wHole Story About Fenestrations in LSEC
Karolina Szafranska et al.
FRONTIERS IN PHYSIOLOGY (2021)
Tumor-Associated Macrophages and Their Functional Transformation in the Hypoxic Tumor Microenvironment
Zicong He et al.
FRONTIERS IN IMMUNOLOGY (2021)
Interferon and Hepatitis B: Current and Future Perspectives
Jianyu Ye et al.
FRONTIERS IN IMMUNOLOGY (2021)
Tumor NLRP3-Derived IL-1β Drives the IL-6/STAT3 Axis Resulting in Sustained MDSC-Mediated Immunosuppression
Isak W. Tengesdal et al.
FRONTIERS IN IMMUNOLOGY (2021)
Enhancement of the Tolerogenic Phenotype in the Liver by ImmTOR Nanoparticles
Petr O. Ilyinskii et al.
FRONTIERS IN IMMUNOLOGY (2021)
Cholangiocarcinoma
Paul J. Brindley et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Tumor-Associated Neutrophils in Hepatocellular Carcinoma Pathogenesis, Prognosis, and Therapy
Konstantinos Arvanitakis et al.
CANCERS (2021)
Nano-Strategies Targeting the Integrin αvβ3 Network for Cancer Therapy
Tsai-Mu Cheng et al.
CELLS (2021)
HBV Reactivation During the Treatment of Non-Hodgkin Lymphoma and Management Strategies
Xing Cao et al.
FRONTIERS IN ONCOLOGY (2021)
Site-specific glycoproteomic analysis revealing increased core-fucosylation on FOLR1 enhances folate uptake capacity of HCC cells to promote EMT
Li Jia et al.
THERANOSTICS (2021)
CD147 Monoclonal Antibody Targeted Reduction-Responsive Camptothecin Polyphosphoester Nanomedicine for Drug Delivery in Hepatocellular Carcinoma Cells
Hongrui Tian et al.
ACS APPLIED BIO MATERIALS (2021)
A dual-functional nanovehicle with fluorescent tracking and its targeted killing effects on hepatocellular carcinoma cells
Xiaojie Zhang et al.
RSC ADVANCES (2021)
Oxaliplatin and Gedatolisib (PKI-587) Co-Loaded Hollow Polydopamine Nano-Shells with Simultaneous Upstream and Downstream Action to Re-Sensitize Drugs-Resistant Hepatocellular Carcinoma to Chemotherapy
Yin-Ci Zhang et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2021)
Molecular and cellular mechanisms of liver fibrosis and its regression
Tatiana Kisseleva et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Therapeutic applications of AS1411 aptamer, an update review
Rezvan Yazdian-Robati et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)
Challenges in liver cancer and possible treatment approaches
David Anwanwan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)
Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy
Xu Lei et al.
CANCER LETTERS (2020)
Exploring Dysregulated Signaling Pathways in Cancer
Sabah Nisar et al.
CURRENT PHARMACEUTICAL DESIGN (2020)
Mechanisms of liver fibrosis and its role in liver cancer
Debanjan Dhar et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2020)
Chemokines and their receptors promoting the recruitment of myeloid-derived suppressor cells into the tumor
Bao-Hua Li et al.
MOLECULAR IMMUNOLOGY (2020)
Antitumor immunity of low-dose cyclophosphamide: changes in T cells and cytokines TGF-beta and IL-10 in mice with colon-cancer liver metastasis
Xiao-Ming Huang et al.
GASTROENTEROLOGY REPORT (2020)
Interferon-Free Hepatitis C Virus Therapy
Jean-Michel Pawlotsky
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2020)
Macrophage Phenotype and Function in Liver Disorder
Lang Dou et al.
FRONTIERS IN IMMUNOLOGY (2020)
Exogenous Liposomal Ceramide-C6 Ameliorates Lipidomic Profile, Energy Homeostasis, and Anti-Oxidant Systems in NASH
Francesca Zanieri et al.
CELLS (2020)
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis
Qing Ye et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook
Josep Garcia et al.
CANCER TREATMENT REVIEWS (2020)
Homotypic cell membrane-cloaked biomimetic nanocarrier for the accurate photothermal-chemotherapy treatment of recurrent hepatocellular carcinoma
Yingxue Sun et al.
JOURNAL OF NANOBIOTECHNOLOGY (2020)
Nanoparticle Delivery of MnO2 and Antiangiogenic Therapy to Overcome Hypoxia-Driven Tumor Escape and Suppress Hepatocellular Carcinoma
Chih-Chun Chang et al.
ACS APPLIED MATERIALS & INTERFACES (2020)
Hepatitis B virus biology and life cycle
Senko Tsukuda et al.
ANTIVIRAL RESEARCH (2020)
Hyaluronic acid derivative-modified nano-structured lipid carrier for cancer targeting and therapy
Xiao Liu et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2020)
Targeting Cancer Associated Fibroblasts in Liver Fibrosis and Liver Cancer Using Nanocarriers
Leonard Kaps et al.
CELLS (2020)
In Search of Zonation Markers to Identify Liver Functional Disorders
Qiuyuan Yang et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
Transcriptome and proteome profiling reveal complementary scavenger and immune features of rat liver sinusoidal endothelial cells and liver macrophages
Sabin Bhandari et al.
BMC MOLECULAR AND CELL BIOLOGY (2020)
EASL recommendations on treatment of hepatitis C: Final update of the series
Jean-Michel Pawlotsky et al.
JOURNAL OF HEPATOLOGY (2020)
Rational design and latest advances of codelivery systems for cancer therapy
Q. Y. Meng et al.
MATERIALS TODAY BIO (2020)
Coating biomimetic nanoparticles with chimeric antigen receptor T cell-membrane provides high specificity for hepatocellular carcinoma photothermal therapy treatment
Weijie Ma et al.
THERANOSTICS (2020)
In vivo Targeting of Liver Cancer with Tissue- and Nuclei-Specific Mesoporous Silica Nanoparticle-Based Nanocarriers in mice
Ziqiang Ding et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)
Virological Basis for the Cure of Chronic Hepatitis B
Jin Hu et al.
ACS INFECTIOUS DISEASES (2019)
Hepatotoxicity induced by immune checkpoint inhibitors: a comprehensive review including current and alternative management strategies
Joseph J. Jennings et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2019)
Transferrin receptor 1 overexpression is associated with tumour de-differentiation and acts as a potential prognostic indicator of hepatocellular carcinoma
Makiko Adachi et al.
HISTOPATHOLOGY (2019)
Doxorubicin-loaded Fe3O4-ZIF-8 nano-composites for hepatocellular carcinoma therapy
Chong Cheng et al.
JOURNAL OF BIOMATERIALS APPLICATIONS (2019)
Recent Advances in Cell Penetrating Peptide-Based Anticancer Therapies
Justine Habault et al.
MOLECULES (2019)
Use of Polymeric Nanoparticle Platform Targeting the Liver To Induce Treg-Mediated Antigen-Specific Immune Tolerance in a Pulmonary Allergen Sensitization Model
Qi Liu et al.
ACS NANO (2019)
In vitro and in vivo mechanism of hepatocellular carcinoma inhibition by β-TCP nanoparticles
Langlang Liu et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Natural biodegradable polymers based nano-formulations for drug delivery: A review
Archana George et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
From NASH to HCC: current concepts and future challenges
Quentin M. Anstee et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
The Role of the Thymus in the Immune Response
Puspa Thapa et al.
THORACIC SURGERY CLINICS (2019)
Relaxin gene delivery mitigates liver metastasis and synergizes with check point therapy
Mengying Hu et al.
NATURE COMMUNICATIONS (2019)
Gold nano-particles (AuNPs) carrying miR-326 targets PDK1/AKT/c-myc axis in hepatocellular carcinoma
Yichao Mo et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2019)
Ontogeny of Tumor-Associated Macrophages
Marie Laviron et al.
FRONTIERS IN IMMUNOLOGY (2019)
IL-10 promoter hypomethylation is associated with increased IL-10 expression and poor survival in hepatocellular carcinoma
Xianjing Zhang et al.
TRANSLATIONAL CANCER RESEARCH (2019)
Glycyrrhetinic acid-modified graphene oxide mediated siRNA delivery for enhanced liver-cancer targeting therapy
Ying Qu et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Peritumoural CCL1 and CCL22 expressing cells in hepatocellular carcinomas shape the tumour immune infiltrate
Gabriela M. Wiedemann et al.
PATHOLOGY (2019)
Liver-Mediated Adaptive Immune Tolerance
Meijuan Zheng et al.
FRONTIERS IN IMMUNOLOGY (2019)
TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis-Updated 2019
Bedair Dewidar et al.
CELLS (2019)
Nano-Gold Loaded with Resveratrol Enhance the Anti-Hepatoma Effect of Resveratrol In Vitro and In Vivo
Duoduo Zhang et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2019)
Chemically modified liposomes carrying TRAIL target activated hepatic stellate cells and ameliorate hepatic fibrosis in vitro and in vivo
Qinghua Li et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients
Barbara Testoni et al.
JOURNAL OF HEPATOLOGY (2019)
CD44 standard isoform is involved in maintenance of cancer stem cells of a hepatocellular carcinoma cell line
Ryoma Asai et al.
CANCER MEDICINE (2019)
Dexamethasone Conjugation to Biodegradable Avidin-Nucleic-Acid-Nano-Assemblies Promotes Selective Liver Targeting and Improves Therapeutic Efficacy in an Autoimmune Hepatitis Murine Model
Martina Bruna Violatto et al.
ACS NANO (2019)
Theranostic Nanodots with Aggregation-Induced Emission Characteristic for Targeted and Image-Guided Photodynamic Therapy of Hepatocellular Carcinoma
Yang Gao et al.
THERANOSTICS (2019)
Polymeric micelles loading with ursolic acid enhancing anti-tumor effect on hepatocellular carcinoma
Meiling Zhou et al.
JOURNAL OF CANCER (2019)
Selective targeting of tumor cells and tumor associated macrophages separately by twin-like core-shell nanoparticles for enhanced tumor-localized chemoimmunotherapy
Tianqi Wang et al.
NANOSCALE (2019)
Hepatitis B Vaccine and Immunoglobulin: Key Concepts
Saibal Das et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2019)
Paclitaxel-loaded nanoparticles decorated with bivalent fragment HAb18 F(ab′)2 and cell penetrating peptide for improved therapeutic effect on hepatocellular carcinoma
Cheng Jin et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2018)
Analyzing 2000 in Vivo Drug Delivery Data Points Reveals Cholesterol Structure Impacts Nanoparticle Delivery
Kalina Paunovska et al.
ACS NANO (2018)
IL-6 Mediates Cross-Talk between Tumor Cells and Activated Fibroblasts in the Tumor Microenvironment
Tatiana A. Karakasheva et al.
CANCER RESEARCH (2018)
An overview on Vadimezan (DMXAA): The vascular disrupting agent
Amir Daei Farshchi Adli et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2018)
Strategies for the treatment of HBV/HDV
Andreas Krause et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Hypoxia and tumor angiogenesis in the era of hepatocellular carcinoma transarterial loco-regional treatments
Mario Petrillo et al.
FUTURE ONCOLOGY (2018)
Sphingosine kinase 1 promotes liver fibrosis by preventing miR-19b-3p-mediated inhibition of CCR2
Tian Lan et al.
HEPATOLOGY (2018)
Vitamin A-coupled liposome system targeting free cholesterol accumulation in hepatic stellate cells offers a beneficial therapeutic strategy for liver fibrosis
Hirotaka Furuhashi et al.
HEPATOLOGY RESEARCH (2018)
Vitamin A-decorated biocompatible micelles for chemogene therapy of liver fibrosis
Jian-Bin Qiao et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Determinants of fibrosis progression and regression in NASH
Detlef Schuppan et al.
JOURNAL OF HEPATOLOGY (2018)
Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors
Eleonora De Martin et al.
JOURNAL OF HEPATOLOGY (2018)
Activation of the HGF/c-Met axis in the tumor microenvironment: A multispecies model
Anna Konstorum et al.
JOURNAL OF THEORETICAL BIOLOGY (2018)
Overexpression of glypican-3 is a predictor of poor prognosis in hepatocellular carcinoma An updated meta-analysis
Jian Zhang et al.
MEDICINE (2018)
Targeted and synergistic therapy for hepatocellular carcinoma: monosaccharide modified lipid nanoparticles for the co-delivery of doxorubicin and sorafenib
Wendu Duan et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
Hypoxia-Driven immunosuppressive Metabolites in the Tumor Microenvironment: New Approaches for Combinational immunotherapy
Yiliang Li et al.
FRONTIERS IN IMMUNOLOGY (2018)
Actively Targeted Magnetothermally Responsive Nanocarriers/Doxorubicin for Thermochemotherapy of Hepatoma
Minghua Li et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Targeting Nanocarriers with Anisamide: Fact or Artifact?
Athanasia Dasargyri et al.
ADVANCED MATERIALS (2017)
Dendritic cells as gatekeepers of tolerance
Ari Waisman et al.
SEMINARS IN IMMUNOPATHOLOGY (2017)
Polyethylene glycol-poly(ε-benzyloxycarbonyl-llysine)-conjugated VEGF siRNA for antiangiogenic gene therapy in hepatocellular carcinoma
Gangmin Wang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Resveratrol-loaded glycyrrhizic acid-conjugated human serum albumin nanoparticles wrapping resveratrol nanoparticles: Preparation, characterization, and targeting effect on liver tumors
Mingfang Wu et al.
JOURNAL OF BIOMATERIALS APPLICATIONS (2017)
SiRNA-mediated in vivo gene knockdown by acid-degradable cationic nanohydrogel particles
Nadine Leber et al.
JOURNAL OF CONTROLLED RELEASE (2017)
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
JOURNAL OF HEPATOLOGY (2017)
The biology of Hepatocellular carcinoma: implications for genomic and immune therapies
Galina Khemlina et al.
MOLECULAR CANCER (2017)
Novel strategies in vaccine design: can nanocapsules help prevent and treat hepatitis B?
Stephan Gehring et al.
NANOMEDICINE (2017)
Autoimmune hepatitis: standard treatment and systematic review of alternative treatments
Benedetta Terziroli Beretta-Piccoli et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Overcoming sorafenib evasion in hepatocellular carcinoma using CXCR4-targeted nanoparticles to co-deliver MEK-inhibitors
Yunching Chen et al.
SCIENTIFIC REPORTS (2017)
Hepatocellular Carcinomas Originate Predominantly from Hepatocytes and Benign Lesions from Hepatic Progenitor Cells
Krishna S. Tummala et al.
CELL REPORTS (2017)
Antibody-Directed Glucocorticoid Targeting to CD163 in M2-type Macrophages Attenuates Fructose-Induced Liver Inflammatory Changes
Pia Svendsen et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2017)
The stellate cell system (vitamin A-storing cell system)
Haruki Senoo et al.
ANATOMICAL SCIENCE INTERNATIONAL (2017)
EGFR Signaling in Liver Diseases
Karin Komposch et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Role of aetiology in the progression, regression, and parenchymal remodelling of liver disease: implications for liver biopsy interpretation
Alberto Quaglia et al.
HISTOPATHOLOGY (2016)
Glycyrrhetinic Acid Mediated Drug Delivery Carriers for Hepatocellular Carcinoma Therapy
Yuee Cai et al.
MOLECULAR PHARMACEUTICS (2016)
Improving the efficacy and safety of biologic drugs with tolerogenic nanoparticles
Takashi K. Kishimoto et al.
NATURE NANOTECHNOLOGY (2016)
Hepatic Steatosis: Etiology, Patterns, and Quantification
Ilkay S. Idilman et al.
SEMINARS IN ULTRASOUND CT AND MRI (2016)
Corona-Directed Nucleic Acid Delivery into Hepatic Stellate Cells for Liver Fibrosis Therapy
Zhengping Zhang et al.
ACS NANO (2015)
TGF-β Regulates Hepatocellular Carcinoma Progression by Inducing Treg Cell Polarization
Yinan Shen et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Cushing's syndrome: update on signs, symptoms and biochemical screening
Lynnette K. Nieman
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
Prevalence of Hepatitis A virus (HAV) and Hepatitis E virus (HEV) in the patients presenting with acute viral hepatitis
A. Joon et al.
INDIAN JOURNAL OF MEDICAL MICROBIOLOGY (2015)
Nanoparticle-based autoantigen delivery to Treg-inducing liver sinusoidal endothelial cells enables control of autoimmunity in mice
Antonella Carambia et al.
JOURNAL OF HEPATOLOGY (2015)
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
Brent A. Neuschwander-Tetri et al.
LANCET (2015)
The Use of Nanoparticles to Deliver Nitric Oxide to Hepatic Stellate Cells for Treating Liver Fibrosis and Portal Hypertension
Hien T. T. Duong et al.
SMALL (2015)
Hepatoma-derived growth factor/nucleolin axis as a novel oncogenic pathway in liver carcinogenesis
San-Cher Chen et al.
ONCOTARGET (2015)
In Vivo Gene-Silencing in Fibrotic Liver by siRNA-Loaded Cationic Nanohydrogel Particles
Leonard Kaps et al.
ADVANCED HEALTHCARE MATERIALS (2015)
KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins
Giusi Marrone et al.
GUT (2015)
Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance
Roberto A. Maldonado et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Anti-CD163-dexamethasone protects against apoptosis after ischemia/reperfusion injuries in the rat liver
Lin Nanna Okholm Moller et al.
ANNALS OF MEDICINE AND SURGERY (2015)
pH-Sensitive Nanoformulated Triptolide as a Targeted Therapeutic Strategy for Hepatocellular Carcinoma
Daishun Ling et al.
ACS NANO (2014)
Therapeutic efficacy of improved α-fetoprotein promoter-mediated tBid delivered by folate-PEI600-cyclodextrin nanopolymer vector in hepatocellular carcinoma
Bao-guang Hu et al.
EXPERIMENTAL CELL RESEARCH (2014)
TGF-β-dependent induction of CD4+CD25+Foxp3+ Tregs by liver sinusoidal endothelial cells
Antonella Carambia et al.
JOURNAL OF HEPATOLOGY (2014)
Relaxin decreases the severity of established hepatic fibrosis in mice
Robert G. Bennett et al.
LIVER INTERNATIONAL (2014)
The types of hepatic rnyofibroblasts contributing to liver fibrosis of different etiologies
Jun Xu et al.
FRONTIERS IN PHARMACOLOGY (2014)
Inhibition of inflammatory CD4 T cell activity by murine liver sinusoidal endothelial cells
Antonella Carambia et al.
JOURNAL OF HEPATOLOGY (2013)
Enhanced Effectivity of an ALK5-Inhibitor after Cell-Specific Delivery to Hepatic Stellate Cells in Mice with Liver Injury
Marike Marjolijn van Beuge et al.
PLOS ONE (2013)
Dual ligands modified double targeted nano-system for liver targeted gene delivery
Fanbo Jing et al.
PHARMACEUTICAL BIOLOGY (2013)
A meta-analysis comparing simultaneous versus delayed resections in patients with synchronous colorectal liver metastases
A. A. P. Slesser et al.
SURGICAL ONCOLOGY-OXFORD (2013)
CD44 antibody-targeted liposomal nanoparticles for molecular imaging and therapy of hepatocellular carcinoma
Lina Wang et al.
BIOMATERIALS (2012)
Ameliorative effect of silibinin against N-nitrosodimethylamine-induced hepatic fibrosis in rats
Devaraj Ezhilarasan et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2012)
Role of Differentiation of Liver Sinusoidal Endothelial Cells in Progression and Regression of Hepatic Fibrosis in Rats
Guanhua Xie et al.
GASTROENTEROLOGY (2012)
Targeted Delivery of Chemotherapy Agents Using a Liver Cancer-Specific Aptamer
Ling Meng et al.
PLOS ONE (2012)
Role of liver sinusoidal endothelial cells and stabilins in elimination of oxidized low-density lipoproteins
Ruomei Li et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2011)
Treatment of autoimmune hepatitis: A review of current and evolving therapies
Dinesh Jothimani et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Reduction of Fibrogenesis by Selective Delivery of a Rho Kinase Inhibitor to Hepatic Stellate Cells in Mice
M. M. van Beuge et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Peptide-Modified Albumin Carrier Explored as a Novel Strategy for a Cell-Specific Delivery of Interferon Gamma To Treat Liver Fibrosis
Ruchi Barisal et al.
MOLECULAR PHARMACEUTICS (2011)
Bioimaging for Targeted Delivery of Hyaluronic Acid Derivatives to the Livers in Cirrhotic Mice Using Quantum Dots
Ki Su Kim et al.
ACS NANO (2010)
The Role of Liver Sinusoidal Cells in Hepatocyte-Directed Gene Transfer
Frank Jacobs et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Hepatic stellate cell (vitamin A-storing cell) and its relative - past, present and future
Haruki Senoo et al.
CELL BIOLOGY INTERNATIONAL (2010)
Immune tolerance: What is unique about the liver
Gisa Tiegs et al.
JOURNAL OF AUTOIMMUNITY (2010)
Priming of CD4+ T Cells by Liver Sinusoidal Endothelial Cells Induces CD25low Forkhead Box Protein 3- Regulatory T Cells Suppressing Autoimmune Hepatitis
Nils Kruse et al.
HEPATOLOGY (2009)
Hepatic Regulatory T Cells and Kupffer Cells Are Crucial Mediators of Systemic T Cell Tolerance to Antigens Targeting Murine Liver
Ekaterina Breous et al.
HEPATOLOGY (2009)
Human Liver Dendritic Cells Promote T Cell Hyporesponsiveness
Zubin M. Bamboat et al.
JOURNAL OF IMMUNOLOGY (2009)
Liver Sinusoidal Endothelial Cells Depend on Mannose Receptor-Mediated Recruitment of Lysosomal Enzymes for Normal Degradation Capacity
Kjetil Elvevold et al.
HEPATOLOGY (2008)
Hydrophilic Monodisperse Magnetic Nanoparticles Protected by an Amphiphilic Alternating Copolymer
Eleonora V. Shtykova et al.
JOURNAL OF PHYSICAL CHEMISTRY C (2008)
Hepatocellular carcinoma cell-specific peptide ligand for targeted drug delivery
Albert Lo et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Selectins and selectin ligands in extravasation of cancer cells and organ selectivity of metastasis
Stephanie Gout et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases
Su Young Kim et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
Prognosis of perihilar cholangiocarcinoma: Hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus
Tsuyoshi Sano et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Hepatitis B virus (HBV) and autoimmune disease
Ram Maya et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2008)
Risk factors of biliary tract cancer in a large-scale population-based cohort study in Japan (JPHC study); with special focus on cholelithiasis, body mass index, and their effect modification
Seiji Ishiguro et al.
CANCER CAUSES & CONTROL (2008)
RNAi-mediated inhibition of COL1A1 and COL3A1 in human skin fibroblasts
Qiong Wang et al.
EXPERIMENTAL DERMATOLOGY (2007)
The mannose receptor on murine liver sinusoidal endothelial cells is the main denatured collagen clearance receptor
Ivana Malovic et al.
HEPATOLOGY (2007)
A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A
Riki Kawaguchi et al.
SCIENCE (2007)
HAb18G/CD147 functions in invasion and metastasis of hepatocellular carcinoma
Jing Xu et al.
MOLECULAR CANCER RESEARCH (2007)
Defects in cGMP-PKG pathway contribute to impaired NO-dependent responses in hepatic stellate cells upon activation
RE Perri et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics
ZH Li et al.
FASEB JOURNAL (2005)
The preferential homing of a platelet derived growth factor receptor-recognizing macromolecule to fibroblast-like cells in fibrotic tissue
L Beljaars et al.
BIOCHEMICAL PHARMACOLOGY (2003)
The role of virus-specific CD8+ cells in liver damage and viral control during persistent hepatitis B virus infection
MK Maini et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Successful targeting to rat hepatic stellate cells using albumin modified with cyclic peptides that recognize the collagen type VI receptor
L Beljaars et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)